VSP Global focuses on investments in eye care and vision-related technologies, primarily in early to mid-stage companies. Their investments span various sectors within the vision care industry, including diagnostic tools, imaging technologies, and innovative eyewear solutions. While specific investment sizes are not disclosed, their portfolio suggests a range from seed to Series C rounds.
Notable portfolio companies include EyeNetra, a mobile eye testing technology provider, and NeuroVision Imaging, which develops retinal imaging for early detection of Alzheimer's disease. VSP Global leverages its industry expertise and extensive network in the vision care sector to provide strategic support and market access to its portfolio companies, enhancing their growth potential and market reach.
VSP Global - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Seed1 (33.3%)
Series A1 (33.3%)
Series C1 (33.3%)
Stage Mix
Seed 33%Series A 33%Series C 33%
Concentration shown as share of disclosed investments by stage.
